Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, anno
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Bioxytran’s 8K filing here. About Bioxytran (Get Free Report) Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The […]
More Stories
Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement
On January 9, 2025, Protagenic Therapeutics, Inc. announced that it has entered into Amendment No. 1 to the At Market...
Weather, Power, and Water Issues Persist in Los Angeles’ Eaton Fire Area
By Beige Luciano-Adams LOS ANGELES—Residents eager to return home and survey vast damage wrought by the Eaton Canyon Fire in...
Titanium Transportation Group (CVE:TTR) Share Price Passes Below 50 Day Moving Average – Should You Sell?
Titanium Transportation Group Inc. (CVE:TTR – Get Free Report)’s share price passed below its 50 day moving average during trading...
Invesco Aerospace & Defense ETF (NYSEARCA:PPA) Stock Price Passes Below 50-Day Moving Average – Here’s Why
Invesco Aerospace & Defense ETF (NYSEARCA:PPA – Get Free Report) shares crossed below its fifty day moving average during trading...
ImmuPharma (LON:IMM) Shares Up 4.9% – What’s Next?
ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 4.9% during mid-day trading on Saturday . The company...
Omineca Mining and Metals (CVE:OMM) Stock Price Down 15.4% – Here’s Why
Omineca Mining and Metals Ltd. (CVE:OMM – Get Free Report)’s stock price traded down 15.4% on Saturday . The company...